How much is Edison Scientific worth in 2026?

Edison Scientific has a current valuation of N/A based on their Seed Round round and secondary market data.

How much funding has Edison Scientific raised?

Edison Scientific has raised N/A in total funding across 1 funding rounds.

Edison Scientific

Drug Discovery

Edison Scientific valuation and funding history | Last updated: December 18, 2025 | 1 funding rounds

Current Valuation

N/A

As of December 18, 2025

Total Funding Raised

N/A

Across 1 round

Last Round

Seed Round

$70.0M

Last Funding

Dec 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
December 18, 2025	Seed Round	$70.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Edison Scientific is currently valued at N/A as of December 18, 2025.

Track Edison Scientific Valuation Updates

Get notified when Edison Scientific raises new funding or valuation changes

Explore More Data

Detailed analysis for Edison Scientific

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Edison Scientific's valuation history, funding rounds, and growth metrics.

No credit card required

What is Edison Scientific Worth in 2026?

Edison Scientific is a leading private company in the Drug Discovery sector. Track Edison Scientific's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Edison Scientific Valuation is Determined

Private company valuations like Edison Scientific's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.